Article

Levamisole-Mediated Suppression of B-Cell Proliferation and Antibody Production Reveals Mechanistic Insights into Idiopathic Nephrotic Syndrome Therapy

2025-12-27

Abstract excerpt

Levamisole (LMS) is a small imidazole derivative with immunomodulatory properties. Despite its longstanding clinical use in Idiopathic Nephrotic Syndrome (INS), the mechanisms underlying its immune-regulating effects remain poorly defined. In this study, we investigated the in vitro effects of LMS treatment on human B-cells, and in patients included from the LEARNS ( LE vamisole as A djuvant therapy to R educe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6b8aa4c6-680b-572e-b2d0-1a874d729677
DOI: 10.64898/2025.12.23.695947

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Levamisole-Mediated Suppression of B-Cell Proliferation and Antibody Production Reveals Mechanistic Insights into Idiopathic Nephrotic Syndrome TherapyDOI 10.64898/2025.12.23.695947Read

Levamisole suppresses activation and proliferation of human T cells by the induction of a p53-dependent DNA damage responseSemantic proximity Read

Immune and molecular landscape behind non-response to Mycophenolate Mofetil and Azathioprine in lupus nephritis therapySemantic proximity Read

Lupus nephritis: the evolving role of novel therapeutics.Semantic proximity Read

B-Cell Dysregulation in Idiopathic Nephrotic Syndrome: What We Know and What We Need to Discover.Semantic proximity Read

Soluble and cell-based markers of immune checkpoint inhibitor associated nephritisSemantic proximity Read

The extrafollicular B cell response is a hallmark of childhood idiopathic nephrotic syndromeSemantic proximity Read

Pathogenesis of minimal change nephrotic syndrome: an immunological conceptSemantic proximity Read

Modeling a biofluid-derived extracellular vesicle surface signature to differentiate pediatric idiopathic nephrotic syndrome clinical subgroupsSemantic proximity Read

Biologic therapies for lupus nephritis: a systematic review of efficacy, safety, and cost-effectivenessSemantic proximity Read

B cell phenotype, activity, and function in idiopathic nephrotic syndrome.Semantic proximity Read

Pharmacogenetics and Pharmacokinetics of Immunosuppressants: Clinical Correlations and Disease Activity Control in Egyptian Female Patients with Lupus Nephritis.Semantic proximity Read

Next-Generation Bruton’s tyrosine kinase Inhibitors plus Rituximab for Chronic Lymphocytic Leukemia-associated Membranoproliferative Glomerulonephritis: A Case ReportSemantic proximity Read